Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Boehringer Ingelheim

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 7,943,317

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,943,317
Title:Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment
Abstract: This invention relates to nucleotide polymorphisms in the human Apo(a) gene and to the use of Apo(a) nucleotide polymorphisms in identifying whether a human subject will respond or not to treatment with acetylsalicylic acid.
Inventor(s): Ridker; Paul (Chestnut Hill, MA), Chasman; Daniel (Somerville, MA), Shiffman; Dov (Palo Alto, CA)
Assignee: The Brigham and Women\'s Hospital, Inc. (Boston, MA) Applera Corporation (Norwalk, CT)
Application Number:12/118,060
Patent Claims:see list of patent claims

Details for Patent 7,943,317

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up The Brigham and Women\'s Hospital, Inc. (Boston, MA) Applera Corporation (Norwalk, CT) 2027-05-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.